Apogee Therapeutics Inc (APGE)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -24.31M | -42.6M | -38.18M | -44.12M | -58.69M |
| Pre Tax Income | -20.84M | -31.74M | -32.09M | -33.82M | -49.02M |
| Net Income | -20.84M | -31.74M | -32.09M | -33.82M | -49.02M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 |
| EBIT | -24.31M | -42.6M | -38.18M | -44.12M | -58.69M |
| EBITDA | -24.31M | -42.6M | -38.18M | -44.06M | -58.64M |
| Year End December 30 2023 | 2023 |
|---|---|
| USD ($) | |
| Total Revenue | 0 |
| Operating Income | -93M |
| Pre Tax Income | -83.99M |
| Net Income | -83.99M |
| Preferred Dividends | 0 |
| Basic Earnings Per Share (EPS) | -1.657 |
| EBIT | -93M |
| EBITDA | -93M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
